Skip to main content

Peer Review reports

From: Long-term efficacy of lenvatinib for recurrent papillary thyroid carcinoma after multimodal treatment and management of complications: a case report

Original Submission
16 Oct 2017 Submitted Original manuscript
27 Oct 2017 Reviewed Reviewer Report - Jo-Pai Chen
2 Nov 2017 Reviewed Reviewer Report - Hsiang-Fong Kao
6 Dec 2017 Author responded Author comments - Masayuki Tori
Resubmission - Version 2
6 Dec 2017 Submitted Manuscript version 2
12 Dec 2017 Reviewed Reviewer Report - Hsiang-Fong Kao
13 Dec 2017 Reviewed Reviewer Report - Jo-Pai Chen
15 Dec 2017 Author responded Author comments - Masayuki Tori
Resubmission - Version 3
15 Dec 2017 Submitted Manuscript version 3
2 May 2018 Reviewed Reviewer Report - F Pitoia
29 May 2018 Author responded Author comments - Masayuki Tori
Resubmission - Version 4
29 May 2018 Submitted Manuscript version 4
15 Jun 2018 Author responded Author comments - Masayuki Tori
Resubmission - Version 5
15 Jun 2018 Submitted Manuscript version 5
Publishing
20 Jun 2018 Editorially accepted
28 Jun 2018 Article published 10.1186/s12885-018-4612-2

You can find further information about peer review here.

Back to article page